RecallCheckr

Serious recall: Injury is possible or has been reported. Take action promptly.

Pharmacy Plus, Inc. dba Vital Care Compounder 2023-04-26 Health serious FDA
Health · FDA · Recall #FDA-D-0538-2023

C-Semaglutide 5mg/mL injection, 0.5mL vials, Rx only, Vital Care Compounder 115 South… Recall

Issued April 26, 2023 · Pharmacy Plus, Inc. dba Vital Care Compounder

In April 2023, Pharmacy Plus, Inc. dba Vital Care Compounder recalled the C-Semaglutide 5mg/mL injection, 0.5mL vials, Rx only, Vital Care Compounder 115 South…, a serious health recall reported by the FDA. Affected owners are eligible for a voluntary. Here is what the hazard is and exactly what to do about it.

Compiled by Maya Ellison, RecallCheckr

What this means for you

Lack of assurance of sterility.

What you should do

  1. 1 Stop using C-Semaglutide 5mg/mL injection, 0.5mL vials, Rx only, Vital Care Compounder 115 South… right away.
  2. 2 Set it aside where it won't be used by mistake.
  3. 3 Contact Pharmacy Plus, Inc. dba Vital Care Compounder to arrange your voluntary. See the official notice below for contact details.
  4. 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):

Recall details

Brand
Pharmacy Plus, Inc. dba Vital Care Compounder
Category
Health
Recall date
April 26, 2023
Units affected
Not reported
Sold at
MS only
Recall number
FDA-D-0538-2023
Made in
United States
Issuing agency
FDA

In context

Read the official FDA notice

Related recalls